Gonorrhoea vaccine - ImClone/Wyeth

Drug Profile

Gonorrhoea vaccine - ImClone/Wyeth

Alternative Names: Neisseria gonorrhoeae vaccine - ImClone/Wyeth Vaccines

Latest Information Update: 25 Nov 2004

Price : $50

At a glance

  • Originator ImClone Systems
  • Class Bacterial vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No

Highest Development Phases

  • Discontinued Gonorrhoea

Most Recent Events

  • 25 Nov 2004 Discontinued - Phase-I for Gonorrhoea in USA (unspecified route)
  • 25 Mar 2002 American Home Products has changed its name and the names of its subsidiaries Wyeth-Ayerst and Wyeth-Lederle to Wyeth
  • 21 Jun 2001 This compound is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top